Recall Register

Food, drugs, devices

Drug recall: Amlodipine besylate and Atorvastatin calcium tablets, 5mg/10mg, packaged in a)30-count bottle (NDC 43598-322-30), b) 90-

FDA enforcement event 71375 · Class III · initiated 6 May 2015 · status Terminated · terminated 31 Mar 2016

DrugVoluntary: Firm initiated4 product recordsPrinceton, NJ

an individual recalling firm (name withheld) (Princeton, NJ) initiated this drug recall on 6 May 2015; FDA lists 4 product records under event 71375, classified Class III.

FDA defines Class III as a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences. 31% of the 292 drug enforcement events initiated in 2015 carry the same class.

Status: Terminated, terminated 31 Mar 2016. Initiation: voluntary: firm initiated.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Individual recalling firm (name withheld), Princeton, NJ. FDA names an individual as the recalling firm; this site does not publish people's names.

Reason for recall

"Subpotent drug"

Distribution

"Nationwide"

Product records

Recall numberProductQuantityClassStatusReport date
D-1143-2015Amlodipine besylate and Atorvastatin calcium tablets, 5mg/10mg, packaged in a)30-count bottle (NDC 43598-322-30), b) 90-count bottle (NDC 43598-322-90), Rx Only, Manufactured by Dr. Reddy's Laboratories Limited Bachupally, 500 090 India—Class IIITerminated24 Jun 2015
D-1144-2015Amlodipine besylate and Atorvastatin calcium tablets, 10mg/10mg, packaged in a)30-count bottle (NDC 43598-321-30), b) 90-count bottle (NDC 43598-321-90), Rx Only, Manufactured by Dr. Reddy's Laboratories Limited Bachupally, 500 090 India—Class IIITerminated24 Jun 2015
D-1145-2015Amlodipine besylate and Atorvastatin calcium tablets, 10mg/40mg, 90-count bottle, Rx Only Manufactured by Dr. Reddy's Laboratories Limited Bachupally, 500 090 India, NDC 43598-315-90—Class IIITerminated24 Jun 2015
D-1146-2015Amlodipine besylate and Atorvastatin calcium tablets, 5mg/40mg packaged in a)30-count bottle (NDC 43598-316-30), b) 90-count bottle (NDC 43598-316-90), Rx Only, Manufactured by Dr. Reddy's Laboratories Limited Bachupally, 500 090 India—Class IIITerminated24 Jun 2015

Context

31%of 2015 drug events are Class III292 events that year
4product records in this event
1event on this register for the firm

Questions and answers

Why was this drug recalled?

FDA's record gives the reason for recall as: "Subpotent drug"

What does Class III mean?

FDA classifies recalls by relative degree of health hazard. Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.

Where was the product distributed?

FDA's distribution pattern field reads: "Nationwide"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 31 Mar 2016. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA drug enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.